Controlled Release of Diphosphonates from Synthetic Polymers to Inhibit Calcification
- 1 April 1987
- journal article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 2 (2) , 266-289
- https://doi.org/10.1177/088532828700200205
Abstract
Calcification is the most frequent cause of the failure of bioprosthetic heart valves fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. Formulation and evaluation of controlled-release drug delivery system to inhibit bioprosthetic heart valve calcification is reviewed.Keywords
This publication has 28 references indexed in Scilit:
- Anatomic analysis of removed prosthetic heart valves: Causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983Human Pathology, 1985
- Inhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release DiphosphonateScience, 1985
- Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.Circulation, 1985
- Ionescu-Shiley Pericardial Xenografts: Follow-up of Up to 6 YearsThe Annals of Thoracic Surgery, 1985
- Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valvesThe American Journal of Cardiology, 1983
- Clinical Durability of the Pericardial Xenograft Valve: Ten Years' Experience with Mitral ReplacementThe Annals of Thoracic Surgery, 1982
- Calcific deposits developing in a bovine pericardial bioprosthetic valve 3 days after implantation.Circulation, 1981
- Factors Determining Outcome of Cardiac Valve ReplacementThe Annals of Thoracic Surgery, 1979
- Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves: Transmission and scanning electron microscopic observations in 12 patientsThe American Journal of Cardiology, 1978
- Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valvesThe American Journal of Cardiology, 1977